The study protocol of this case-control cross-sectional study was approved by Cairo University Hospital Research Committee. The study and data collection conformed to all local laws and were compliant with the principles of the Declaration of Helsinki.
Children with T1DM were recruited from the outpatients' clinic of the Diabetes, Endocrine, & Metabolism Pediatric Unit (DEMPU) of the Kasr Alainy Hospitals in the period from January 2015 to December 2015. Our inclusion criteria were patients in the age group (5–18 years), diagnosed with T1DM for a minimum duration of 5 years with normal fundus examination and having no recent change in their visual acuity. Children having glaucoma, previous ocular trauma, ocular surgery, refractive errors >+5 and <−8 diopter sphere, best-corrected visual acuity (BCVA) < 20/25, or any other coexisting ocular pathology were excluded from the study.
A healthy control group (n = 50) of normal children was matched for sex and age. They did not have any history of ocular disease or relevant systemic disease, nor family history of glaucoma nor any relevant systemic disease. They were coming to the pediatric ophthalmology clinic for minor complaints and/or refractive error correction.
All patients underwent physical examination, by a pediatric endocrinologist. Age, sex, and onset and duration of TIDM were recorded. The following parameters were measured: HbA1c, total cholesterol (TC), triglycerides (TG), serum creatinine, urine creatinine, thyroid stimulating hormone (TSH), and free thyroxin (T4). Height, weight, body mass index, as well as the daily insulin dose taken by these children and their blood pressure were also recorded.
Patients underwent a full ophthalmic examination. Slit-lamp examination for the anterior segment as well as IOP measurements were taken. Visual acuity was measured using an Early Treatment Diabetic Retinopathy Study (ETDRS) chart at 4 m. Best-corrected visual acuity was recorded as Snellen equivalent. Fundus examination by a retina specialist was carried out after pupil dilation with 0.5% phenylephrine hydrochloride and 0.1% tropicamide, with indirect ophthalmoscope as well as by slit-lamp biomicroscopy. The clinical grading of DR used by the retina specialist was based on the ETDRS grading scheme. This scheme classified DR into mild and moderate nonproliferative DR (background DR), severe nonproliferative retinopathy (pre-proliferative DR) and non-high-risk and high-risk proliferative DR (proliferative DR).
34 Absence of any of these findings by clinical examination was considered as a normal fundus.